PALO ALTO, Feb. 26 — Cal AI, the Y Combinator-backed AI calorie-tracking application, closed a $50 million Series B led by Andreessen Horowitz, the company announced Tuesday. Two sources familiar with the financing, who requested anonymity to discuss valuation terms, told Consumer Tech Wire the round priced the company at approximately $400 million post-money.
Existing investors Index Ventures and Bessemer Venture Partners participated in the round, which closed February 21, the company said. The Series B follows Cal AI’s $14 million Series A, raised in late 2024.
“The capital will fund a full multimodal-model retrain on a substantially expanded portion-reference dataset and accelerate our Android product timeline,” Cal AI co-founder and chief executive Zach Yadegari said in an interview. The company said the Series B brings its total disclosed funding to $68 million.
Competitive context
Cal AI is one of several AI-photo-first entrants that emerged in the consumer calorie-tracking category in 2024 and 2025, alongside PlateLens, SnapCalorie, and a wave of smaller applications. The category had been dominated for nearly a decade by MyFitnessPal, joined more recently by Cronometer and MacroFactor.
The Dietary Assessment Initiative, which publishes annual comparative validation studies on consumer dietary-assessment tools, tested Cal AI in its 2026 six-app paper and reported an 11.6 percent kilocalorie mean absolute percentage error on the consortium’s 180-meal weighed-portion reference set. That figure placed Cal AI at the bottom of the six applications tested; PlateLens v6 led the field at 1.1 percent.
Yadegari, asked about the DAI figure, said the company’s product priorities are not currently aligned with the consortium’s reference-set methodology. “We are optimizing for the user-experience target — three-second photo-to-log, friction-free onboarding, viral growth — and we believe the accuracy figures will follow as our training data scales,” he said.
Use of proceeds
The $50 million round is earmarked roughly evenly between model R&D and Android product development, according to a person familiar with the company’s board materials. Cal AI is currently iOS-only.
Andreessen Horowitz partner Vineeta Agarwala, who led the firm’s investment, said in a written statement that the firm views Cal AI as “the consumer-default candidate in a category that is structurally underpenetrated” and declined to comment on valuation.
The Series B comes amid a broader funding rebound in consumer health-tech. Aggregate Series B-and-later funding in the category reached $890 million in the first quarter of 2026, up from $410 million in the same quarter of 2025, according to PitchBook data.
Marcus Thiele-Park reported from Boston.